- Report
- August 2025
- 187 Pages
Global
From €3299EUR$3,545USD£2,759GBP
€3666EUR$3,939USD£3,066GBP
- Report
- August 2025
- 189 Pages
Global
From €3299EUR$3,545USD£2,759GBP
€3666EUR$3,939USD£3,066GBP
- Report
- August 2025
- 197 Pages
Global
From €3299EUR$3,545USD£2,759GBP
€3666EUR$3,939USD£3,066GBP
- Report
- August 2025
- 191 Pages
Global
From €3299EUR$3,545USD£2,759GBP
€3666EUR$3,939USD£3,066GBP
- Report
- August 2025
- 196 Pages
Global
From €3299EUR$3,545USD£2,759GBP
€3666EUR$3,939USD£3,066GBP
- Report
- August 2025
- 180 Pages
Global
From €3299EUR$3,545USD£2,759GBP
€3666EUR$3,939USD£3,066GBP
- Report
- August 2025
- 186 Pages
Global
From €3299EUR$3,545USD£2,759GBP
€3666EUR$3,939USD£3,066GBP
- Report
- October 2025
- 150 Pages
Global
From €5538EUR$5,950USD£4,631GBP
- Report
- September 2025
- 130 Pages
Global
From €5538EUR$5,950USD£4,631GBP
- Report
- May 2025
- 120 Pages
Global
From €5538EUR$5,950USD£4,631GBP
- Report
- January 2025
- 130 Pages
Global
From €5538EUR$5,950USD£4,631GBP
- Report
- February 2023
- 180 Pages
Global
From €5538EUR$5,950USD£4,631GBP
- Report
- November 2024
- 136 Pages
Global
From €5119EUR$5,500USD£4,281GBP
- Report
- August 2024
- 75 Pages
Europe
From €2746EUR$2,950USD£2,296GBP
- Report
- February 2024
- 169 Pages
Global
From €4607EUR$4,950USD£3,853GBP
- Report
- October 2024
- 200 Pages
Global
From €3490EUR$3,750USD£2,919GBP
- Report
- May 2024
- 200 Pages
Global
From €3862EUR$4,150USD£3,230GBP
- Report
- May 2024
- 200 Pages
Global
From €3862EUR$4,150USD£3,230GBP
- Report
- January 2024
- 200 Pages
Global
From €3862EUR$4,150USD£3,230GBP
- Report
- November 2022
- 54 Pages
Global

The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein.
The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more